• About Us
  • Company Overview
  • Management
  • Board of Directors
  • Scientific Team
  • Investors
  • Careers
  • Contact Us
  • Email Sign-up
• Algae Products
  • The CO2 Problem
  • The Algae Solution
  • Algae Oil
  • Biodiesel
  • Animal Nutrition
  • Other Co-products
• Technology
  • Core Technology
  • Culture Collection
  • Intellectual Property
  • Publications
• Production Facilities
  • Pilot
  • Demonstration
  • Commercial
• Partners
  • Why Partner with Us
  • Shell/Cellana
  • Power Plants
  • Cement Plants
  • Ethanol Plants
  • Other Partners
• News & Media
  • News
  • Events
  • FAQ
  • Press Kit
  • Image Libary

MANAGEMENT

Take a moment to meet HR BioPetroleum's senior management team. We are a group of biotechnology and industry professionals dedicated to the future of a cleaner, greener, more energy-secure future.

Edward T. Shonsey, M.B.A.
Chief Executive Officer & Member of the Board

Mr. Shonsey has been the CEO and a member of the Board of Directors of HRBP since January 2008.  He has an impressive record of executive management and leadership experience across several industries, including the industrial and ag biotechnology and agribusiness industries. Prior to joining HRBP, from 2005 to 2007, Mr. Shonsey was the CEO of Diversa Corporation, a public biotechnology company focused on the discovery, development, large-scale manufacture, and commercialization of industrial enzymes for a variety of applications, including ethanol, biodiesel, and other biofuels, where he led a highly successful strategic repositioning of the company and oversaw a doubling of the market capitalization. Prior to Diversa, Mr. Shonsey was the President and Chief Executive Officer of Syngenta Seeds Inc. / Northrup King, Inc. (formerly Sandoz Seeds and Novartis Seeds) where he led the launch of the first agricultural biotech product which was named global product of the year. While at Northrup King, he acquired and/or integrated nine separate corporations and was part of the leadership team that merged Sandoz and Ciba-Geigy (creating Novartis) and, subsequently, Novartis and Astra-Zeneca agricultural companies (creating Syngenta). Previous to that, Mr. Shonsey held senior level executive positions at Global Trading Resources (GTR), an international trade, customs clearance and strategic planning corporation he founded. Before that, Mr. Shonsey spent ten years at Pioneer Hi-Bred International, Inc. (now subsidiary of DuPont Corporation), where he served as Senior Vice President; Chief Financial Officer; Sr. Vice President, International Operations, Administration and Human Resources, and Business Development. Mr. Shonsey began his career at Procter & Gamble serving as an Operations Manager. Mr. Shonsey has a B.S. in Electrical Engineering from Marquette University and an M.B.A. from Creighton University.

Martin Sabarsky, JD, MBA
Chief Financial Officer & Chief Operating Officer

Mr. Sabarsky has been CFO and COO of HRBP since August 2008 after consulting for the Company from December 2007 through July 2008. He has significant leadership experience in the industrial biotechnology industry, as well as extensive transactional experience across multiple industries, including the biotechnology industry, having worked as an investment banker and attorney on over $13 billion of transactions in aggregate. Prior to joining HRBP, from 2000 to 2007, he led the corporate development function at Diversa Corporation and led a number of additional functions within the Finance and Accounting department during his tenure with Diversa, with increasing levels of management responsibility, most recently as Vice President of Corporate Development and a member of the Executive Committee. Before Diversa, Mr. Sabarsky worked from 1999 to 2000 as an investment banker with Bear, Stearns & Co. Inc., where he focused on financings and mergers and acquisitions within the life sciences industry and was a lead banker on Diversa’s $200 million IPO in February 2000. Prior to joining Bear Stearns, from 1995 to 1999, he worked as a transactional attorney with Latham & Watkins LLP, where he focused on the corporate, securities, and tax aspects of financings and mergers and acquisitions for clients in the real estate, healthcare, venture capital, and biotechnology industries, among others. Mr. Sabarsky has an A.B. in Biology and Political Science from Brown University, a J.D. from Harvard Law School, and an M.B.A. from the Rady School of Management at the University of California, San Diego.

Mark Huntley, PhD.,
Chief Scientific Officer, Co-Founder, & Member of the Board

A co-founder of HRBP, Dr. Huntley is a thought-leader in marine biological sciences generally and algae cultivation technologies specifically. One of the most frequently-cited researchers in his field, an organizer of global research initiatives, and an entrepreneur, he has been active in algae-related research and development for more than 20 years. He has held research faculty positions at both the Scripps Institution of Oceanography and the University of Hawaii. Dr. Huntley held a senior management role for 10 years in the GLOBEC program, a $300 million international program investigating the impact of global change on marine ecosystems. As an entrepreneurial CEO, he took Aquasearch Inc., a marine biotechnology company focused on the production of astaxanthan and other value-added products from cultivated marine microalgae, from start-up to a public market valuation of $200 million in four years. Dr. Huntley is skilled at organizing interdisciplinary R&D programs. Dr. Huntley received his Ph.D. in Biological Oceanography from Dalhousie University.